Allergan's medical devices division had an 18.4 percent increase in net sales in the first quarter ended March 31, and its sales of specialty pharmaceuticals rose by 9.7 percent. These were increases of 13.4 percent and 5.6 percent on a currency-neutral basis, respectively. The Californian company saw overall net sales ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.